ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements
National Peroxide Limited appointed Mr. Amit Shah as General Manager – Sales & Marketing, effective 11 November 2026, as a senior management personnel change. The appointment was approved at a board meeting held the same day.
National Peroxide Ltd reported revenue from operations of ₹112 Cr (+64.0% YoY) and net profit of ₹0.9 Cr (+125.0% YoY) for Q2 FY27.
National Peroxide Limited has scheduled a board meeting for November 11, 2026. The board will consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
National Peroxide Ltd has submitted its quarterly shareholding pattern filing for the period ended September 30, 2026. This is a routine regulatory disclosure under SEBI Regulation 31.
National Peroxide Limited announced CEO Rajiv Arora's resignation, effective November 2, 2026. Vinay Divakar Jayade will succeed him as CEO and Whole-Time Director, effective November 3, 2026.
National Peroxide Ltd held its 6th Annual General Meeting on September 29, 2026. Members considered resolutions including financial statement adoption and a final dividend declaration.
National Peroxide Limited has issued a notice for its 6th Annual General Meeting scheduled for September 29, 2026. The meeting will address financial statements, dividends, and director re-appointments.
National Peroxide Limited issued a communication to shareholders providing the web-link to access the 6th AGM Notice and the Annual Report for FY 2025-26.
National Peroxide Limited has filed its Annual Report for FY 2025-26 and the notice for the upcoming 6th Annual General Meeting scheduled for September 29, 2026.
National Peroxide Limited has re-appointed M/s. Kalyaniwalla & Mistry LLP as its Statutory Auditor for a term of 60 months.
National Peroxide Ltd reported revenue from operations of ₹96.1 Cr (+44.1% YoY) and net profit of ₹6.6 Cr (+633.3% YoY) for Q1 FY27.
National Peroxide Limited scheduled a board meeting for August 12, 2026, to consider and approve revised financial results and un-audited results for the current quarter.
National Peroxide Ltd has scheduled a Board Meeting for August 03, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.
National Peroxide Ltd has filed its quarterly shareholding pattern for the period ending June 30, 2026. This is a routine regulatory disclosure.
Mr. Rajeev Pradhan has resigned as Chief Information Officer of National Peroxide Limited. His resignation is effective from the close of business on July 15, 2026.
National Peroxide Limited submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report by Parikh & Associates confirms overall regulatory compliance during the period.
National Peroxide Ltd reported revenue from operations of ₹85.7 Cr (+16.3% YoY) and net profit of ₹7.9 Cr for Q4 FY26.
National Peroxide Ltd reported a net profit of ₹11.04 Crore for the financial year ended March 31, 2026. The Board recommended a final dividend of 70% (₹7 per share). Additionally, the company appointed Mr. Chirag Kothari as CFO and CRO, succeeding Mr. Amit Goriwale effective June 1, 2026.
National Peroxide Ltd has scheduled a Board Meeting for April 30, 2026. The board will consider and approve audited financial results for the quarter and year ended March 31, 2026, and may recommend a dividend for the same period.